Conventional treatments of Alzheimer's disease, one of the most common forms of dementia, have been largely focused on ...

TechBio company MultiOmic Health (MOH) initially set out to build an artificial intelligence (AI)-enabled platform to research metabolic dysfunction-associated conditions. In just three years, not ...

PALO ALTO, Calif., May 1, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to ...

SÃO PAULO--(BUSINESS WIRE)--Following a US$ 3 million seed investment in 2022, Nintx (Next Innovative Therapeutics), a biotech company researching and developing treatments for multifactorial diseases ...

Dry eye syndrome (DES) is a complex, multifactorial condition that can escalate into an irreversible chronic inflammatory disease if not treated in its early stages. As discussed in the Overview ...

Steatotic liver disease (commonly called fatty liver disease) progresses silently. Even in the absence of noticeable symptoms ...

Forbes contributors publish independent expert analyses and insights. Greg Licholai writes and teaches about innovation in healthcare. This week delivered a sobering reminder that Alzheimer’s disease ...

A new review was published in Volume 17, Issue 12 of Aging-US on December 30, 2025, titled “Aging as a multifactorial ...

Interview has been edited for readability. AJMC®: What percentage of your practice is dedicated to treating dry eye disease (DED), and has this changed over time? Devries: Approximately 90% of my ...

Proteins form the building blocks of life, but when they form unusual clumps inside the brain, they raise an alarm that ...